$RYTM

$89.47 +$0.20 (0.22%) Close

$RYTM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$RYTM Management Team

Dr. David Meeker

Chairman of the Board

President

Chief Executive Officer

Age 70

Compensation $14.66M USD

Sex Male

Mr. Hunter Smith

Chief Financial Officer

Treasurer

Age 57

Compensation $5.050M USD

Sex Male

Ms. Pamela Cramer

Chief Human Resources Officer

Age 51

Compensation -

Sex Female

Ms. Jennifer Lee

Executive Vice President

Head of North America

Age 50

Compensation $4.318M USD

Sex Female

Mr. Yann Mazabraud

Executive Vice President

Head of International

Age 52

Compensation $5.622M USD

Sex Male

Mr. Joseph Shulman

Chief Technical Officer

Age 50

Compensation $3.410M USD

Sex Male

Dr. Alastair Garfield

Chief Scientific Officer

Age 45

Compensation -

Sex Male

Mr. David Connolly

Head of Investor Relations and Corporate Communications

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Dr. David Meeker Chairman of the Board President Chief Executive Officer	70	$14.66M USD	Male
Mr. Hunter Smith Chief Financial Officer Treasurer	57	$5.050M USD	Male
Ms. Pamela Cramer Chief Human Resources Officer	51	-	Female
Ms. Jennifer Lee Executive Vice President Head of North America	50	$4.318M USD	Female
Mr. Yann Mazabraud Executive Vice President Head of International	52	$5.622M USD	Male
Mr. Joseph Shulman Chief Technical Officer	50	$3.410M USD	Male
Dr. Alastair Garfield Chief Scientific Officer	45	-	Male
Mr. David Connolly Head of Investor Relations and Corporate Communications	-	-	Male

Board of Directors

From the proxy statement filed Apr 29, 2026

Directors

serving now

Independent

6 of 6

stated in the proxy; 1 not stated

Average tenure

7.6 years

from year joined

CEO also chairs the board

Yes

David P. Meeker, M.D.

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Stuart A. Arbuckle	60	2019 7 years	Independent	Governance & Nominating Committee · Chair	Alnylam Pharmaceuticals, Inc., Praxis Precision Medicines, Inc.	$659,981
Jennifer Good	61	2019 7 years	Independent	None stated	None stated	$659,981
Christophe R. Jean	70	2015 11 years	Independent	None stated	None stated	$659,981
David W.J. McGirr	71	2015 11 years	Independent	Audit Committee · Chair	Insmed Incorporated	$674,981
David P. Meeker, M.D. Board chair, CEO	71	2015 11 years	Not stated	None stated	Pharvaris GmbH	Paid as CEO
Kimberly J. Popovits	67	2026 0 years	Independent	None stated	10x Genomics, Inc., Kiniksa Pharmaceuticals International, plc	Not stated
Lynn A. Tetrault, J.D. Lead independent director	63	2020 6 years	Independent	Compensation & Management Development Committee · Chair	NeoGenomics, Inc., Alumis, Inc.	$669,981

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$RYTM Management Team

Dr. David Meeker

Mr. Hunter Smith

Ms. Pamela Cramer

Ms. Jennifer Lee

Mr. Yann Mazabraud

Mr. Joseph Shulman

Dr. Alastair Garfield

Mr. David Connolly

Board of Directors

Related-party transactions

No related-party transactions disclosed